Liquid 2 Ventures

Founded in 2015, Liquid 2 Ventures is a venture capital firm based in San Francisco, California. It specializes in seed-stage investments for technology startups.

Michael Ma

General Partner

Mike Miller

General Partner

Nathaniel Montana

General Partner

Elizabeth Montana-Luciano

Director of Operations

Matthew Mulvey

Partner

Past deals in Health Diagnostics

Contrast

Pre Seed Round in 2023
Contrast is a health care technology company delivering an AI-powered electronic health record and charting platform designed to streamline clinical workflow. The solution aims to improve the medical history experience with three core upgrades beyond traditional charting: a user-friendly interface, task automation, and voice-enabled dictation that empowers physicians to automate keyboard and mouse actions. It leverages existing patient data, integrates with current record systems, and combines AI and automation within a modern UI to help healthcare providers manage higher patient volumes, enhance care quality, and increase operational efficiency.

Scanbase

Pre Seed Round in 2023
Scanbase is a company that focuses on enhancing the diagnostic journey for patients by developing innovative digital care planning and management tools. Its platform transforms traditional analog tests into digital workflows that integrate with application programming interfaces (APIs). This capability allows medical companies to analyze patient risk through photographs of rapid diagnostic tests and provide immediate results. By leveraging advanced computer vision technology, Scanbase aims to improve the efficiency and accuracy of at-home diagnostics, positioning itself as a leader in the evolving landscape of diagnostic medicine. The company is adaptable and responsive to unique situations, ensuring that it remains at the forefront of technological advancements in healthcare.

Kivo Health

Venture Round in 2023
Kivo Health is a telehealth company specializing in lung care. It offers an eight-week clinical program led by live therapists, aiming to reduce symptoms and manage chronic obstructive pulmonary disease.

Menda Health

Pre Seed Round in 2023
Menda Health is a healthcare company specializing in online programs designed to treat chronic pain by addressing its root causes. They employ an evidence-based neuroplasticity approach, combining virtual video sessions with licensed therapists and personalized neural training plans.

Kivo Health

Pre Seed Round in 2022
Kivo Health is a telehealth company specializing in lung care. It offers an eight-week clinical program led by live therapists, aiming to reduce symptoms and manage chronic obstructive pulmonary disease.

Ambience Healthcare

Series A in 2022
Ambience Healthcare is a developer of an advanced artificial intelligence-powered medical scribe that aims to enhance clinician efficiency and alleviate burnout. Its Ambience AI operating system features a suite of synergistic applications designed to capture the nuances of clinician-patient conversations in real-time, generating comprehensive notes that integrate seamlessly into electronic medical record workflows. The system employs state-of-the-art speech recognition and custom-built AI to produce documentation in seconds while accommodating individual clinician preferences to reflect their unique style and voice. By utilizing Ambience's technology, healthcare systems can significantly reduce documentation time by an average of 78%, improve coding integrity, and achieve substantial returns on investment, ultimately enabling clinicians to close all their charts by the end of their shifts and achieve a better work-life balance.

Zephyr AI

Seed Round in 2022
Zephyr AI is a healthcare technology company focused on transforming drug discovery and precision medicine. By leveraging large complex datasets and proprietary algorithms, Zephyr AI aims to redefine drug development and streamline clinical trials. The company collaborates with leading health systems, health insurance plans, and biotechnology innovators to enhance healthcare quality, improve patient outcomes, and reduce costs. Through its innovative approach, Zephyr AI seeks to address challenges in disease treatment and clinical decision support, ultimately contributing to advancements in the healthcare sector.

Uh-Oh Labs

Venture Round in 2022
Uh-Oh Labs is a diagnostics and health technology company that works to improve public health by developing low-cost, accurate diagnostics. It also develops diagnostic tests through its Loop-de-Loop platform. They provide infectious disease testing, the COVID-19 Test, which includes a reusable instrument and disposable test kits.

NyquistAI

Pre Seed Round in 2021
NyquistAI is a developer of a global data platform that specializes in transforming unstructured life science data into actionable insights. By leveraging advanced machine learning technology, NyquistAI connects various data sources, including global clinical trials and real-world information, to offer a comprehensive view of the Medtech landscape. The platform is designed to help healthcare professionals access and compile critical life science data, enabling them to make informed decisions in research and business strategy development. NyquistAI aims to provide a customizable experience that equips users with credible, up-to-date content and expertise throughout the entire innovation lifecycle, thereby facilitating enhanced research and the identification of new opportunities within the life sciences sector.

Akute Health

Seed Round in 2021
AkuteHealth specializes in developing patient management software tailored for direct care clinics, offering a simple and mobile-friendly electronic health record (EHR) system. The software enhances efficiency for healthcare professionals by automating tasks and providing data visualization options. It includes features such as lab ordering, which allows users to request and receive lab results electronically, and the ability to send and receive faxes directly within the platform. This functionality helps reduce administrative overhead while improving patient care. Patients benefit from the platform as well, enjoying the convenience of self-scheduling appointments and easily accessing and sharing their medical records. Overall, AkuteHealth’s solutions aim to streamline operations for healthcare providers while enhancing the patient experience.

Pirouette Medical

Series A in 2021
Pirouette Medical specializes in developing portable and user-friendly auto-injectors. Its initial product is an epinephrine auto-injector for emergency treatment of severe allergic reactions, designed with a human-centered approach to address major pain points.

SafeBeat Rx

Pre Seed Round in 2021
SafeBeat Rx is a technology company specializing in advanced electrocardiogram solutions aimed at enhancing cardiac care. The company has developed software that facilitates remote patient monitoring, continuous telemetry, and event monitoring, significantly reducing the need for prolonged hospital stays for cardiac patients. By leveraging automated artificial intelligence, SafeBeat Rx's technology allows for safe medication initiation for arrhythmia patients while enabling effective monitoring of cardiac implantable electronic devices. This innovative approach expands access to cardiac care, allowing patients to receive essential services from the comfort of their homes.

Akute Health

Pre Seed Round in 2021
AkuteHealth specializes in developing patient management software tailored for direct care clinics, offering a simple and mobile-friendly electronic health record (EHR) system. The software enhances efficiency for healthcare professionals by automating tasks and providing data visualization options. It includes features such as lab ordering, which allows users to request and receive lab results electronically, and the ability to send and receive faxes directly within the platform. This functionality helps reduce administrative overhead while improving patient care. Patients benefit from the platform as well, enjoying the convenience of self-scheduling appointments and easily accessing and sharing their medical records. Overall, AkuteHealth’s solutions aim to streamline operations for healthcare providers while enhancing the patient experience.

Genomelink

Seed Round in 2021
Genomelink operates a digital genetic analysis platform that lets individuals upload their raw DNA data to generate reports on traits, wellness, ancestry, and nutrition. The service translates genomic information into user-friendly interpretations for personal exploration and genetic self-knowledge. It emphasizes data privacy by upholding user ownership of data, implementing ISO-certified security, and offering options to delete data. The company positions itself as a consumer-focused provider of accessible, detailed genomic insights, supporting informed health and lifestyle decisions while ensuring control and transparency over personal genetic information.

Harmonize

Series A in 2021
Harmonize is a company that specializes in a remote care platform aimed at enhancing the management of high-risk patients, particularly those who may struggle with technology and have multiple health conditions. Founded in 2019 and headquartered in San Mateo, California, Harmonize's platform streamlines technology implementation and clinical triage, enabling healthcare organizations to provide effective remote care. The interface is designed to accommodate both high-tech and high-touch inputs, facilitating improved patient engagement and adherence rates. By guiding healthcare staff through triage and intervention processes at scale, Harmonize significantly reduces operational overhead while promoting better patient outcomes and lowering healthcare costs.

Reperio Health

Seed Round in 2021
Reperio Health offers an innovative at-home health assessment platform designed for preventive care. It collects multiple health metrics in real-time, including blood pressure, resting heart rate, body mass index (BMI), relative fat mass, cholesterol levels, and glucose levels. The platform enables individuals to monitor their health conveniently while ensuring accessibility to essential health information through AI-assisted virtual visits with licensed medical professionals.

Rupa Health

Venture Round in 2020
Rupa Health operates an online platform that facilitates access to alternative healthcare providers and streamlines the process of ordering lab tests. Founded in 2018 and based in San Francisco, the company offers a comprehensive service that enables doctors to order specialty lab work, manage samples, and receive results efficiently. The platform integrates seamlessly with various lab companies, allowing healthcare professionals to order multiple tests in one place without requiring membership or subscription fees. Rupa Health also provides flexible payment options and robust support for both practitioners and patients, ensuring an efficient lab experience. The company's services include shipping test reports directly to patients' homes, simplifying the management and tracking of lab results to enhance patient care.

Done.

Seed Round in 2020
Done is a digital health company that specializes in providing personalized online treatment for individuals with ADHD. Founded in 2019 and headquartered in San Francisco, California, Done aims to enhance access to accessible and affordable psychiatric care. The company operates a hybrid ADHD clinic that offers both virtual and in-person appointments, allowing patients to discuss symptoms, treatment options, and concerns with qualified clinicians. By focusing on treatment management, Done seeks to improve the lives of those affected by ADHD, which can often lead to challenges in work performance and interpersonal relationships. Through its platform, Done enables patients to receive ongoing psychiatric care, making it easier for them to navigate their healthcare journey effectively.

Semantic Health

Seed Round in 2020
Semantic Health is a Toronto-based healthcare technology company that uses proprietary artificial intelligence to enhance medical coding, auditing, and clinical documentation improvement processes in hospitals.

Orange Health Labs

Seed Round in 2020
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Angle Health

Seed Round in 2020
Founded in 2019, Angle Health specializes in providing modern health insurance solutions tailored for startups. It offers a comprehensive platform that combines AI-enabled tools, virtual care access, and customizable benefits to streamline administrative tasks and deliver personalized healthcare management.

Getlabs

Seed Round in 2020
Getlabs is a digital health platform that facilitates at-home diagnostics. It enables healthcare organizations to send mobile phlebotomists to patients' homes nationwide for lab draws, vital checks, and advanced diagnostics, improving patient adherence and care gap closure.

H1

Series A in 2020
H1 provides a global healthcare platform that connects life sciences companies, hospitals, academic medical centers, and health systems with providers, enables access to clinical research, helps locate industry experts, and supports benchmarking of organizations. As a trusted source of information on healthcare professionals and institutions, the platform combines real-time data and clinical findings to illuminate the broader healthcare ecosystem. The company, founded in 2017 and based in New York, also offers a healthcare data analytics capability that delivers real-time, end-to-end insights across the data landscape to support therapeutic development—from fundraising and product development to product launch.

Medallion

Pre Seed Round in 2020
Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.

Angle Health

Pre Seed Round in 2020
Founded in 2019, Angle Health specializes in providing modern health insurance solutions tailored for startups. It offers a comprehensive platform that combines AI-enabled tools, virtual care access, and customizable benefits to streamline administrative tasks and deliver personalized healthcare management.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. is a healthcare company that specializes in at-home diagnostic solutions, focusing on urine testing kits. Founded in 2018 and headquartered in Los Angeles, California, Scanwell Health has developed an FDA-cleared urine testing application that allows users to obtain clinical-grade results via their smartphones. The company's flagship product is a urinary tract infection test kit that not only provides accurate testing results but also connects users with online medical professionals for same-day treatment and prescriptions. By combining innovative technology with accessible healthcare services, Scanwell Health aims to enhance proactive health management for individuals seeking convenient and affordable medical care.

Hallow

Seed Round in 2019
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.

Pair Team

Seed Round in 2019
Pair Team provides healthcare coordination services focused on underserved and vulnerable communities. It deploys a dedicated, tech-enabled care team—including community health workers, registered nurses, and behavioral health clinicians—to offer personalized, holistic support to Medicaid and Medicare patients and other low-income individuals facing barriers to care such as transportation, housing and food insecurity, and limited mobile access. The company acts as an extension of safety-net primary care systems, helping them deliver patient-centered care while integrating with community-based organizations. It is building a care delivery platform to standardize clinical practices, streamline administrative tasks, and enable clinicians to spend more time with patients.

Brave Care

Seed Round in 2019
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.

Getlabs

Seed Round in 2019
Getlabs is a digital health platform that facilitates at-home diagnostics. It enables healthcare organizations to send mobile phlebotomists to patients' homes nationwide for lab draws, vital checks, and advanced diagnostics, improving patient adherence and care gap closure.

Viosera

Seed Round in 2019
Viosera Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies to combat antibiotic resistance, particularly targeting methicillin-resistant Staphylococcus aureus (MRSA). Founded in July 2016, the company is headquartered in Sunnyvale, California, with additional operations in St. Louis, Missouri. Viosera's flagship product, VT1, is designed to treat MRSA bloodstream infections. The company employs artificial intelligence to identify and develop drug combinations that predict and block resistance evolution in both bacterial infections and cancer treatment. Through these advancements, Viosera aims to provide effective solutions that address the growing threat of antibiotic resistance, ultimately improving patient outcomes.

Untitled Labs

Seed Round in 2019
Untitled Labs, Inc. is a consumer application idea lab based in San Francisco, California, founded in 2018. The company focuses on testing and developing innovative business ideas in various sectors, including social and professional networking, mobility, personal finance, premium services, health and wellness, travel, photography, and dating. Led by serial entrepreneur Roger Dickey, Untitled Labs aims to create valuable technology products that resonate with large audiences. By systematically evaluating multiple concepts, the company seeks to identify and build a sustainable business around the most promising idea.

Siren Care

Series A in 2018
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Cricket Health

Series A in 2018
Cricket Health Inc. is a specialty kidney care provider that focuses on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, the company employs a technology-enabled, multidisciplinary approach to patient care, offering both in-person and virtual services. Cricket Health aims to enhance patient outcomes while providing value to healthcare partners by prioritizing patient health, reducing hospitalizations, facilitating access to transplants, and promoting home dialysis adoption. The company is dedicated to identifying at-risk patients early, managing disease progression, and delivering personalized care options such as transplant support and various dialysis modalities.

Prime Discoveries

Pre Seed Round in 2018
Prime Discoveries develops microbiome testing, discovery, and diagnostics, leveraging a technology platform that integrates automation, machine learning, and computational biology to enable rapid, scalable solutions for microbiome research and pathogen diagnostics. Founded in 2017 and based in New York, the company serves healthcare and agricultural industries with novel diagnostics and testing services designed to deliver results quickly with minimal lab infrastructure, often under 1 hour, using US-developed assays. The company focuses on cost-effective, automatable assays that address emerging pathogens such as Covid, flu, STIs, and drug-resistant microbes, supporting researchers, clinicians, and public health efforts.

Biobot Analytics

Seed Round in 2018
Biobot Analytics, Inc. is a wastewater epidemiology company based in Cambridge, Massachusetts, founded in 2017. It specializes in transforming wastewater infrastructure into public health observatories through innovative technology that analyzes sewage for health-related data. By deploying proprietary sampling devices and spatial analytics, Biobot measures various health threats, including infectious diseases, antibiotic resistance, and drug consumption patterns. The company's Opioid Consumption Monitoring Program specifically estimates opioid use in urban areas by analyzing wastewater. This approach generates anonymized public health data that is independent of traditional hospital reporting systems, allowing for rapid adaptability to emerging public health threats. Biobot Analytics offers its insights as a service, providing government officials with actionable data to prioritize interventions and address public health challenges effectively.

Siren Care

Seed Round in 2018
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Biobot Analytics

Seed Round in 2018
Biobot Analytics, Inc. is a wastewater epidemiology company based in Cambridge, Massachusetts, founded in 2017. It specializes in transforming wastewater infrastructure into public health observatories through innovative technology that analyzes sewage for health-related data. By deploying proprietary sampling devices and spatial analytics, Biobot measures various health threats, including infectious diseases, antibiotic resistance, and drug consumption patterns. The company's Opioid Consumption Monitoring Program specifically estimates opioid use in urban areas by analyzing wastewater. This approach generates anonymized public health data that is independent of traditional hospital reporting systems, allowing for rapid adaptability to emerging public health threats. Biobot Analytics offers its insights as a service, providing government officials with actionable data to prioritize interventions and address public health challenges effectively.

Medumo

Seed Round in 2018
Medumo, Inc. is a healthcare technology company based in Boston, Massachusetts, founded in 2013. It specializes in automating the delivery of timely instructions to patients through its CareTours platform, which utilizes automated messaging via SMS and email. By integrating mobile communication and artificial intelligence, Medumo empowers healthcare organizations to engage patients effectively without requiring additional resources. The platform allows patients to seek medical advice, manage health records, and receive precise instructions, thereby enhancing patient-provider communication. Medumo aims to improve patient preparedness and reduce the administrative burden on healthcare staff, ultimately fostering a more transparent and informed healthcare environment. The company operates as a subsidiary of Koninklijke Philips N.V. since 2019.

Athelas

Seed Round in 2017
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Athelas

Seed Round in 2017
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Nucleus care

Pre Seed Round in 2016
NucleusCare is a healthcare communication technology company focused on enhancing connectivity among seniors, developmentally disabled individuals, assisted living residents, and home care clients. The company has developed a user-friendly video chat device that enables clients to easily communicate with healthcare providers and family members, ensuring a more supportive and connected environment. In addition to the video chat functionality, NucleusCare offers a web application and mobile app for care coordinators and family members, facilitating efficient communication and coordination of care. The system also includes wireless sensors to monitor biometric data such as blood pressure, heart rate, and weight, promoting proactive health management. By streamlining communication, NucleusCare aims to improve the overall quality of care and provide peace of mind to families, ultimately leading to happier and healthier lives for its users.

Athelas

Seed Round in 2016
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Insight Data Science

Seed Round in 2016
Insight Data Science is an educational organization based in Palo Alto, California, that specializes in post-doctoral training fellowships for data scientists and engineers. Founded in 2012, it offers intensive six-week programs designed to bridge the gap between academia and the data science industry. The fellowship focuses on areas such as data engineering, academic research, and health data science, providing participants with project-based learning experiences alongside industry mentoring. Insight Data Science aims to facilitate the transition of engineers into roles within big data engineering and data science, leveraging a network of mentors from leading technology companies.

Reperio Health

Reperio Health offers an innovative at-home health assessment platform designed for preventive care. It collects multiple health metrics in real-time, including blood pressure, resting heart rate, body mass index (BMI), relative fat mass, cholesterol levels, and glucose levels. The platform enables individuals to monitor their health conveniently while ensuring accessibility to essential health information through AI-assisted virtual visits with licensed medical professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.